SUKHBIR BHURJI: Open Payments
NPI 1255762902 · BOWIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 29 payments from 10 companies in 2025. Trend: 2023 $947 · 2024 $1,002 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 13 | $266 |
| PFIZER INC. | 4 | $99 |
| ABBVIE INC. | 3 | $63 |
| Indivior Inc. | 2 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $34 |
| SPR Therapeutics, Inc | 1 | $26 |
| Globus Medical, Inc. | 1 | $24 |
| Electronic Waveform Lab, Inc. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $21 |
| Valinor Pharma, LLC | 1 | $14 |
Products named: XTAMPZA, NURTEC ODT, SUBLOCADE, UBRELVY, JOURNAVX, SPRINT PNS System, Senza, QUTENZA.
Industry payments across MD — which companies pay providers there.
